blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3653223

EP3653223 - DEVICE FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  23.07.2021
Database last updated on 26.04.2025
FormerGrant of patent is intended
Status updated on  24.03.2021
FormerRequest for examination was made
Status updated on  13.11.2020
FormerThe application has been published
Status updated on  17.04.2020
Most recent event   Tooltip11.02.2025Change - representative 
Applicant(s)For all designated states
Rani Therapeutics, LLC
2051 Ringwood Avenue
San Jose, CA 95131 / US
[2020/21]
Inventor(s)01 / IMRAN, Mir
12894 Brendel Drive
Los Altos Hills, CA California 94022 / US
 [2021/34]
Former [2020/21]01 / IMRAN, Mir
12894 Brendel Drive
Los Altos Hills, CA 94022 / US
Representative(s)Potter, Julian Mark, et al
WP Thompson
138 Fetter Lane
London EC4A 1BT / GB
[N/P]
Former [2020/21]Forrest, Stuart, et al
WP Thompson
138 Fetter Lane
London EC4A 1BT / GB
Application number, filing date19203957.627.06.2012
[2020/21]
Priority number, dateUS201161571641P29.06.2011         Original published format: US 201161571641 P
[2020/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3653223
Date:20.05.2020
Language:EN
[2020/21]
Type: B1 Patent specification 
No.:EP3653223
Date:25.08.2021
Language:EN
[2021/34]
Search report(s)(Supplementary) European search report - dispatched on:EP15.04.2020
ClassificationIPC:A61K38/28, A61B1/04, A61B5/07, A61K9/48
[2020/21]
CPC:
A61M31/002 (EP,AU); A61B5/14539 (EP,AU); A61B5/4839 (EP,AU);
A61B5/073 (EP,AU)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/51]
Former [2020/21]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VORRICHTUNG ZUR ORALEN VERABREICHUNG VON THERAPEUTISCHEN VERBINDUNGEN[2020/21]
English:DEVICE FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS[2020/21]
French:DISPOSITIF POUR L'ADMINISTRATION ORALE DE COMPOSÉS THÉRAPEUTIQUES[2020/21]
Examination procedure09.11.2020Examination requested  [2020/51]
09.11.2020Date on which the examining division has become responsible
25.03.2021Communication of intention to grant the patent
19.07.2021Fee for grant paid
19.07.2021Fee for publishing/printing paid
19.07.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP12804668.7  / EP2726141
Divisional application(s)EP21192893.2  / EP3973983
Opposition(s)Opponent(s)01  25.05.2022  27.05.2022  ADMISSIBLE
Novo Nordisk A/S
Novo Allé
2880 Bagsvaerd / DK
Opponent's representative
Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
 [N/P]
Former [2022/27]
Opponent(s)01  25.05.2022  27.05.2022  ADMISSIBLE
Novo Nordisk A/S
Novo Allé
2880 Bagsvaerd / DK
Opponent's representative
Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
10.06.2022Invitation to proprietor to file observations on the notice of opposition
14.10.2022Reply of patent proprietor to notice(s) of opposition
24.10.2023Date of oral proceedings
15.11.2023Despatch of interlocutory decision in opposition
15.11.2023Despatch of minutes of oral proceedings
Appeal following opposition12.01.2024Appeal received No.  T0081/24
12.01.2024Payment of appeal fee
15.03.2024Statement of grounds filed
12.01.2024Appeal received No.  T0081/24
12.01.2024Payment of appeal fee
14.03.2024Statement of grounds filed
Fees paidRenewal fee
17.10.2019Renewal fee patent year 03
17.10.2019Renewal fee patent year 04
17.10.2019Renewal fee patent year 05
17.10.2019Renewal fee patent year 06
17.10.2019Renewal fee patent year 07
17.10.2019Renewal fee patent year 08
31.03.2020Renewal fee patent year 09
14.06.2021Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.06.2012
AL25.08.2021
CY25.08.2021
CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
MK25.08.2021
MT25.08.2021
RO25.08.2021
RS25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
LU27.06.2022
[2024/44]
Former [2024/25]HU27.06.2012
AL25.08.2021
CY25.08.2021
CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
MK25.08.2021
RO25.08.2021
RS25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
LU27.06.2022
Former [2024/23]AL25.08.2021
CY25.08.2021
CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
MK25.08.2021
RO25.08.2021
RS25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
LU27.06.2022
Former [2024/20]AL25.08.2021
CY25.08.2021
CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
RO25.08.2021
RS25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
LU27.06.2022
Former [2023/21]AL25.08.2021
CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
RO25.08.2021
RS25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
LU27.06.2022
Former [2023/08]AL25.08.2021
CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
RO25.08.2021
RS25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
Former [2022/36]AL25.08.2021
CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
RO25.08.2021
RS25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
Former [2022/29]AL25.08.2021
CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
RO25.08.2021
RS25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
Former [2022/25]CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
RO25.08.2021
RS25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
Former [2022/24]CZ25.08.2021
EE25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
RO25.08.2021
RS25.08.2021
SK25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
Former [2022/10]HR25.08.2021
LT25.08.2021
LV25.08.2021
RS25.08.2021
BG25.11.2021
GR26.11.2021
IS25.12.2021
Former [2022/09]LT25.08.2021
RS25.08.2021
BG25.11.2021
Former [2022/08]LT25.08.2021
BG25.11.2021
Documents cited:Search[A]WO2006077528  (KONINKL PHILIPS ELECTRONICS NV [NL], et al);
 [A]EP1980290  (OLYMPUS CORP [JP]);
 [A]US2008275430  (BELSKY ZIV [IL], et al)
by applicantUS20100978233
 US20100978301
OppositionUS2004253304
 US2006167339
 US2007010709
 EP1980290
 WO2011079302
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.